Immuno Cellular
Immuno Cellular is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of brain and ovarian cancers.
Business Model:
Revenue: $0
Employees: 1-1
Rankings
Industries / Tags:
Detailed Immuno Cellular Information
Geographic Data
Address: 23622 Calabasas Road
City: Calabasas
State: CA
Zip: 91302
Country: US
Financial Info
Stage:
grant
Raised Last:
$20M
Raised Total:$13M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Immuno Cellular is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of brain and ovarian cancers.
Contact Phone:
Contact Email:
Immuno Cellular went public on 1/11/2013 on the OTCMKTS
Listed Exchange:
OTCMKTS
IPO Date:
1/11/2013
Ticker Symbol:
IMUC
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2011 | Venture Round | 1 | $8.1M |
Asset Management Ventures (AMV) Asset Management Ventures (AMV) Asset Management Ventures (AMV) Asset Management Ventures (AMV) |
4/2010 | Venture Round | $1.7M | 3/2010 | Equity | $1.7M | 2/2011 | Equity | $8.1M | 8/2022 | Post-IPO Debt | $750k | 9/2015 | Grant | 1 | $19.9M |
California Institute for Regenerative Medicine California Institute for Regenerative Medicine |
6/2010 | Venture Round | $2.7M | 5/2010 | Equity | $2.7M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
